Point of Care Monitors for Oral Anticoagulant Therapy

ABSTRACT

Over recent years, the use of portable coagulation monitors for prothrombin time-International Normalized Ratio (PT-INR) testing has been gaining popularity. Their advantages over traditional methods of monitoring include ease of use, short test duration, faster turnaround time for dosage changes, increased patient convenience by eliminating the need to go to the laboratory for venipuncture, and increased patient-provider interaction. Portable coagulation monitors for PT-INR testing are currently used in various settings, such as anticoagulation clinics, physician offices, at the patient's bedside in hospital wards, and independently by patients at home. Numerous studies have addressed the suitability of these monitors as alternatives to traditional laboratory testing. Various point of care (POC) coagulation monitors have been developed, and many models are commercially available in the United States. Because technology differs among the various devices, accuracy and precision need to be determined for individual devices. The various devices cannot be used interchangeably, and individual device performance cannot be generalized.

KEYWORDS

Oral anticoagulants - warfarin - point of care devices - monitoring - International Normalized Ratio

REFERENCES

• 1 Ansell J, Hirsh J, Dalen J et al.. Managing oral anticoagulant therapy.  Chest. 2001;  119 22S-38S
• 2 Quick A J. The prothrombin in hemophilia and in obstructive jaundice.  J Biol Chem. 1935;  109 73-74
• 3 Hirsh J. Oral anticoagulant drugs.  N Engl J Med. 1991;  324 1865-1875
• 4 WHO Expert Committee on Biological Standardization .twenty-eighth report. World Health Organ Tech Rep Ser 1977 610 14-16 45-51
• 5 Hirsh J, Poller L. The international normalized ratio.  Arch Intern Med. 1994;  154 282-288
• 6 Koerner S D, Fuller R E. Comparison of a portable capillary whole blood coagulation monitor and standard laboratory methods for determining International Normalized Ratio.  Mil Med. 1998;  163 820-825
• 7 Tripodi A, Chantarangkul V, Mannucci P M. Near-patient testing devices to monitor oral anticoagulant therapy.  Br J Haematol. 2001;  113 847-852
• 8 van den Besselaar A M. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation.  J Thromb Thrombolysis. 2001;  12 35-40
• 9 Anderson D R, Harrison L, Hirsch J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulation therapy.  Arch Intern Med. 1993;  153 1441-1447
• 10 Foulis P R, Wallach P M, Adelman H M et al.. Performance of the Coumatrak system in a large anticoagulation clinic.  Am J Clin Pathol. 1995;  103 98-102
• 11 Lucas F V, Duncan A, Jay R et al.. A novel whole blood capillary technique for measuring the prothrombin time.  Am J Clin Pathol. 1987;  8 442-446
• 12 Yano Y, Kambayashi J, Murata K et al.. Bedside monitoring of warfarin therapy by a whole blood capillary coagulation monitor.  Thromb Res. 1992;  66 583-590
• 13 Weibert R T, Adler D S. Evaluation of a capillary whole blood prothrombin time measurement system.  Clin Pharm. 1989;  8 864-867
• 14 McCurdy S A, White R H. Accuracy and precision of a portable anticoagulation monitor in a clinical setting.  Arch Intern Med. 1992;  152 589-592
• 15 Tripodi A, Arbini A A, Chantarangkul V et al.. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the International Normalized Ratio?.  Thromb Haemost. 1993;  70 921-924
• 16 Roche Diagnostics Corp .Package insert: CoaguChek^™ S. Indianapolis. IN: Roche Diagnostics 2002
• 17 Bayer Diagnostics. Package insert: Rapidpoint Coag™ .Tarrytown, NY; Bayer Diagnostics/Pharmanetics Inc 2002
• 18 Rose V L, Dermott S C, Murray B F et al.. Decentralized testing for prothrombin time and activated partial thromboplastin time using a dry chemistry portable analyzer.  Arch Pathol Lab Med. 1993;  117 611-617
• 19 Oberhardt B J, Dermott S C, Taylor M et al.. Dry reagent technology for rapid, convenient measurements of blood coagulation and fibrinolysis.  Clin Chem. 1991;  37 520-526
• 20 Kapiotis S, Quehenberger P, Speiser W. Evaluation of the new method Coaguchek for the determination of prothrombin time from capillary blood: comparison with Thrombotest on KC-1.  Thromb Res. 1995;  77 563-567
• 21 van den Besselaar A M. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin.  Thromb Haemost. 2000;  84 410-412
• 22 van den Besselaar A M, Meeuwisse-Braun J, Schaefer-van Mansfeld H, van Rijn C, Witteveen E. A comparison between capillary and venous blood international normalized ratio determinations in a portable prothrombin time device.  Blood Coagul Fibrinolysis. 2000;  11 559-562
• 23 Kaatz S S, White R H, Hill J et al.. Accuracy of laboratory and portable monitor international normalized ratio determinations.  Arch Intern Med. 1995;  155 1861-1867
• 24 Biotrack, Inc .Package insert: ProTime^® Microcoagulation System. Mountain View, CA; International Technidyne Corp 2002
• 25 Oral Anticoagulation Monitoring Study Group . Point-of-care prothrombin time measurement for professional and patient self-testing use. A multicenter clinical experience. Oral Anticoagulation Monitoring Study Group.  Am J Clin Pathol. 2001;  115 288-296
• 26 Pierce M T, Crain L, Smith J, Mehta V. Point-of-care versus laboratory measurement of the International Normalized Ratio.  Am J Health Syst Pharm. 2000;  57 2271-2274
• 27 Chapman D C, Stephens M A, Hamann G L et al.. Accuracy, clinical correlation, and patient acceptance of two handheld prothrombin time monitoring devices in the ambulatory setting.  Ann Pharmacother. 1999;  33 775-780
• 28 Reed C, Rickman H. Accuracy of International Normalized Ratio determined by portable whole-blood coagulation monitor versus a central laboratory.  Am J Health Syst Pharm. 1999;  56 1619-1623
• 29 Avocet, Inc .Package insert: AvoSure^™ PT. San Jose, CA; Avocet Medical Inc 2000
• 30 De Miguel D, Burgaleta C, Reyes E, Pascual T. Capillary whole blood testing by a new portable monitor. Comparison with standard determination of the international normalized ratio.  Am J Clin Pathol. 2003;  120 28-33
• 31 Rigelsky J M, Choe H M, Curtis D M et al.. Accuracy of the AvoSure PT Pro System compared with a hospital laboratory standard.  Ann Pharmacother. 2002;  36 380-385
• 32 LifeScan, Inc. Package insert: Harmony™ INR Monitoring System .Milpitas, CA; LifeScan Inc./Johnson & Johnson 2003
• 33 Earp B, Chow H, Sharma A. LifeScan INR monitor: system description and calibration traceability.  J Thromb Thrombolysis. 2001;  12 110
• 34 Earp B, Hambleton J, Spencer F, Jacobson A. Accuracy and precision of the LifeScan INR monitor in anticoagulation clinics.  J Thromb Thrombolysis. 2001;  12 109
• 35 HemoSense, Inc .Product information: INRatio^™ . Milpitas, CA; Hemosense, Inc 2003
• 36 Jacobson A, Peterson M, Gunnemann T et al.. Magnitude of INR variation attributable to differences between point-of-care testing devices.  Thromb Haemost. 2001;  86(Suppl) 802a
• 37 Gosselin R C, Owings J T, White R H et al.. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods.  Thromb Haemost. 2000;  83 698-703
• 38 Ansell J E. Empowering patients to monitor and manage oral anticoagulation therapy.  JAMA. 1999;  281 182-183
• 39 White R H, McCurdy S A, von Marensdorff H et al.. Home prothrombin time monitoring after initiation of warfarin therapy.  Ann Intern Med. 1989;  111 730-737
• 40 Sawicki P T. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial.  JAMA. 1999;  281 145-150
• 41 Ansell J, Patel N, Ostrovsky D et al.. Long-term patient self-management of oral anticoagulation.  Arch Intern Med. 1995;  155 2185-2189
• 42 Bernardo A. Experience with patient self-management of oral anticoagulation.  J Thromb Thrombolysis. 1996;  2 321-325
• 43 Cromheecke M E, Levi M, Colly L P et al.. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomized cross-over comparison.  Lancet. 2000;  356 97-102